Psoriatic Disease

Clinical Guidance

Psoriatic Arthritis

Overview

Genetics and Pathogenesis of Psoriatic Arthritis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

This is a description of an article from Clinical Guidance. This article is about genetics and psoriatic arthitis.

News

August 01, 2024

3 min read

Save

Lack of training leads to delayed dermatology diagnoses in patients with darker skin tones

Poor representation of darker skin tones in dermatology training materials has led to delayed diagnoses and worse treatment outcomes in Black, Asian and non-white Latin American patients, according to a presenter.

Clinical Guidance

Psoriasis

Primary Care

Primary Care Physician Guide to Psoriatic Disease

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Psoriasis

Treatment Options

Phototherapy for Psoriasis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Psoriasis

Treatment Options

Topical Therapy for Psoriasis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Psoriasis

Overview

Epidemiology and Classification of Psoriasis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Psoriasis

Overview

Genetics and Pathogenesis of Psoriasis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Psoriasis

Treatment Options

Biologic Therapy for Psoriasis

Eric M. Ruderman, MD; Kenneth B. Gordon, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News

July 11, 2024

2 min read

Save

Guselkumab brings active psoriatic arthritis into ‘stringent’ control through 2 years

Guselkumab for psoriatic arthritis led to major improvements in joint disease activity, complete skin clearance and other “stringent” endpoints that were maintained through 2 years, according to data published in Clinical Rheumatology.

News

June 26, 2024

2 min read

Save

Bimekizumab results in rapid, sustained improvements to PsA patient reported outcomes

Bimekizumab treatment for psoriatic arthritis demonstrated rapid, clinically meaningful improvements to patient reported outcomes that were sustained up to 1 year, according to data published in Rheumatology.